Your browser doesn't support javascript.
loading
Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy.
Wei, Xiaohui; Naseer, Shabnam; Weinstein, Edward A; Iarikov, Dmitri; Nambiar, Sumathi; Reynolds, Kellie S; Jang, Seong H.
Affiliation
  • Wei X; Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Naseer S; Division of Anti-Infectives, Office of Infectious Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Weinstein EA; Division of Anti-Infectives, Office of Infectious Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Iarikov D; BioNTech US, Cambridge, Massachusetts, USA.
  • Nambiar S; Division of Anti-Infectives, Office of Infectious Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Reynolds KS; Division of Anti-Infectives, Office of Infectious Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Jang SH; Johnson and Johnson, Raritan, New Jersey, USA.
Clin Pharmacol Ther ; 112(5): 1004-1007, 2022 11.
Article in En | MEDLINE | ID: mdl-35792715
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Continuous Renal Replacement Therapy Type of study: Guideline Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Continuous Renal Replacement Therapy Type of study: Guideline Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2022 Type: Article Affiliation country: United States